BioLabs at Pegasus Park

Madrid-Based Cancer Diagnostics Co. Snags Biggest Spec Suite at Pegasus Park’s Bridge Labs

by | Jan 23, 2025
Founded in 2012, Universal DX is focused on "cracking cancer’s code" via its multi-omics and machine learning models. Starting with colorectal cancer, it's building a "multi-cancer platform" that can ID the unique DNA regions associated with different types of cancers.
MORE
American Cancer Society’s BrightEdge Golden Ticket Pitch Competition to Be Held at Pegasus Park
by | Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
MORE
Dallas’ Pegasus Park Expands with New Bridge Labs to Support Biotech Growth
According to an economic impact report by The Perryman Group, the 26-acre Pegasus Park campus, once fully built out under its master plan, is projected to generate $1.9 billion in annual gross product and create over 15,000 jobs.

Bridge Labs, the latest addition to the Pegasus Park campus, is designed to provide high-quality, flexible lab and office space for growth-stage biotech companies. "It's one-of-a-kind in the region," said Nicole Small, CEO of Lyda Hill Philanthropies.
MORE

Bridge Labs at Pegasus Park Aims to Boost the Region’s Burgeoning Life Sciences Ecosystem

by | Jun 15, 2023
The $110 million, 135,000 square-foot expansion at Pegasus Park—a regional hub for life sciences and biotechnology in North Texas—will offer prebuilt lab suites with the tools and flexible space needed for growth-stage life sciences entrepreneurs and companies. Demolition is underway and construction on Bridge Labs is set to begin soon, developers said.
MORE
Bridge Labs Expansion Coming to Pegagus Park in 2024
by | Feb 13, 2023
The new two-story lab and office building will offer "the first institutional-quality space" in the DFW market, according to marketing materials.
MORE
Startup to Storefront: SkinStasis Launches ‘Revolutionary’ Skin Care Product Out of BioLabs at Pegasus Park
Co-founders Paul Stewart and Frank Murdock started up SkinStasis Skin Care earlier this year to meet "a big unmet need" in the cold sore/herpes virus field, where they say there's been "no real new pharmaceutical development" for over 20 years.

Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
MORE